In 2024, 54,045 overdose deaths in the United States involved opioids, accounting for approximately two-thirds of all drug overdose deaths. Although opioid-involved overdose deaths have declined from their peak, they remain a significant public health concern. Buprenorphine is an effective medication for opioid use disorder (MOUD) that reduces opioid use and overdose risk and supports long-term recovery. Ensuring prescribers have the knowledge and confidence to initiate and manage buprenorphine treatment is imperative to expanding access to lifesaving care.
A $250 incentive will be provided to Primary Care Providers (Physicians and Advanced Practice Professionals) who attend this MOUD training. PCPs must also practice in Michigan and not have received an incentive for this training in the past. The incentive will be limited to the first 250 registered primary care providers, so please register early to ensure a spot.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and OPEN: Overdose Prevention Engagement Network. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
